These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30913092)

  • 1. Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath Tumors.
    Shurell-Linehan E; DiPardo BJ; Elliott IA; Graham DS; Eckardt MA; Dry SM; Nelson SD; Singh AS; Kalbasi A; Federman N; Bernthal NM; Eilber FC
    Am J Clin Oncol; 2019 May; 42(5):426-431. PubMed ID: 30913092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
    Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C
    Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.
    LaFemina J; Qin LX; Moraco NH; Antonescu CR; Fields RC; Crago AM; Brennan MF; Singer S
    Ann Surg Oncol; 2013 Jan; 20(1):66-72. PubMed ID: 22878618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma Center.
    Graham DS; Russell TA; Eckardt MA; Motamedi K; Seeger LL; Singh AS; Bernthal NM; Kalbasi A; Dry SM; Nelson SD; Elashoff D; Levine BD; Eilber FC
    Am J Clin Oncol; 2019 Oct; 42(10):739-743. PubMed ID: 31436746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome.
    Zou C; Smith KD; Liu J; Lahat G; Myers S; Wang WL; Zhang W; McCutcheon IE; Slopis JM; Lazar AJ; Pollock RE; Lev D
    Ann Surg; 2009 Jun; 249(6):1014-22. PubMed ID: 19474676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.
    Chou D; Bilsky MH; Luzzati A; Fisher CG; Gokaslan ZL; Rhines LD; Dekutoski MB; Fehlings MG; Ghag R; Varga P; Boriani S; Germscheid NM; Reynolds JJ;
    J Neurosurg Spine; 2017 Mar; 26(3):291-298. PubMed ID: 27834629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group.
    Carli M; Ferrari A; Mattke A; Zanetti I; Casanova M; Bisogno G; Cecchetto G; Alaggio R; De Sio L; Koscielniak E; Sotti G; Treuner J
    J Clin Oncol; 2005 Nov; 23(33):8422-30. PubMed ID: 16293873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas?
    Gladdy RA; Qin LX; Moraco N; Edgar MA; Antonescu CR; Alektiar KM; Brennan MF; Singer S
    J Clin Oncol; 2010 Apr; 28(12):2064-9. PubMed ID: 20308666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Interval Between Preoperative Radiation and Surgery Is Not Associated with Overall Survival for Soft-tissue Sarcomas: An Analysis of the National Cancer Database.
    Collier CD; Kim CY; Liu RW; Getty PJ
    Clin Orthop Relat Res; 2021 Mar; 479(3):506-517. PubMed ID: 32401002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma.
    Greto D; Saieva C; Loi M; Desideri I; Delli Paoli C; Lo Russo M; Pezzulla D; Teriaca MA; Lucidi S; Visani L; Terziani F; Olmetto E; Becherini C; Bonomo P; Francolini G; Campanacci DA; Scoccianti G; Livi L
    Am J Clin Oncol; 2019 Oct; 42(10):749-754. PubMed ID: 31503061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1.
    Dunn GP; Spiliopoulos K; Plotkin SR; Hornicek FJ; Harmon DC; Delaney TF; Williams Z
    J Neurosurg; 2013 Jan; 118(1):142-8. PubMed ID: 23101443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature.
    Montano N; D'Alessandris QG; D'Ercole M; Lauretti L; Pallini R; Di Bonaventura R; La Rocca G; Bianchi F; Fernandez E
    J Neurosurg; 2016 Aug; 125(2):363-71. PubMed ID: 26636382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant peripheral nerve sheath tumors of the trigeminal nerve: a systematic review of 36 cases.
    Schmidt RF; Yick F; Boghani Z; Eloy JA; Liu JK
    Neurosurg Focus; 2013 Mar; 34(3):E5. PubMed ID: 23451818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location.
    Kamran SC; Howard SA; Shinagare AB; Krajewski KM; Jagannathan JP; Hornick JL; Ramaiya NH
    Eur J Surg Oncol; 2013 Jan; 39(1):46-52. PubMed ID: 23084090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical signs of neurofibromatosis impact on the outcome of malignant peripheral nerve sheath tumors.
    Lamm W; Schur S; Köstler WJ; Funovics P; Windhager R; Amann G; Panotopoulos J; Pokrajac B; Brodowicz T
    Oncology; 2014; 86(2):122-6. PubMed ID: 24480823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
    Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
    J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant peripheral nerve sheath tumor: analysis of treatment outcome.
    Wong WW; Hirose T; Scheithauer BW; Schild SE; Gunderson LL
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):351-60. PubMed ID: 9788415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience.
    Stucky CC; Johnson KN; Gray RJ; Pockaj BA; Ocal IT; Rose PS; Wasif N
    Ann Surg Oncol; 2012 Mar; 19(3):878-85. PubMed ID: 21861229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.
    Andreou D; Werner M; Pink D; Traub F; Schuler MK; Gosheger G; Jobke B; Reichardt P; Tunn PU
    Int J Hyperthermia; 2016; 32(2):159-64. PubMed ID: 26670477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant peripheral nerve sheath tumors - Outcomes and prognostic factors based on the reference center experience.
    Sobczuk P; Teterycz P; Czarnecka AM; Świtaj T; Koseła-Paterczyk H; Kozak K; Falkowski S; Goryń T; Zdzienicki M; Morysiński T; Rutkowski P
    Surg Oncol; 2020 Dec; 35():276-284. PubMed ID: 32949967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.